SCHEMBL9745408

SCHEMBL9745408

CCCCOC(=O)Nc1ccc(Cl)c(C(=O)O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.68
NPC1 O15118 10/20 0.68
SMN1; SMN2 Q16637 9/20 0.68
HPGD P15428 6/20 0.68
CYP1A2 P05177 2/20 0.68
CYP2C9 P11712 2/20 0.68
CYP2C19 P33261 2/20 0.68
ALDH1A1 P00352 5/20 0.59
L3MBTL1 Q9Y468 2/20 0.58
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
LMNA P02545 2/20 0.55
KDM4E B2RXH2 4/20 0.54
MAPT P10636 4/20 0.54
CASP1 P29466 1/20 0.54
MAPK1 P28482 1/20 0.54
MCL1 Q07820 1/20 0.54
EPHX2 P34913 1/20 0.51
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10476873 0.86 RAB9A (0.80) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL8604284 0.85 RAB9A (0.59) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL9196939 0.84 SMN1; SMN2 (0.61) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL29666364 0.83 RAB9A (0.70) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL7176133 0.83 RAB9A (0.59) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL8655203 0.82 KDM4E (0.54) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL8748351 0.82 RAB9A (0.57) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL30780905 0.81 RAB9A (0.76) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL1592859 0.81 KDM4E (0.53) RAB9ANPC1SMN1; SMN2HPGDCYP1A2
SCHEMBL1592318 0.81 KDM4E (0.53) RAB9ANPC1SMN1; SMN2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP claimed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO claimed
CN-1051036-A The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound UNIROYAL CHEM CO INC (US) 1991-05-01 CN claimed